BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strobelt R, Adler J, Paran N, Yahalom-Ronen Y, Melamed S, Politi B, Shulman Z, Schmiedel D, Shaul Y. Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism. Sci Rep 2022;12:5758. [PMID: 35388061 DOI: 10.1038/s41598-022-09664-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Abavisani M, Rahimian K, Mahdavi B, Tokhanbigli S, Mollapour Siasakht M, Farhadi A, Kodori M, Mahmanzar M, Meshkat Z. Mutations in SARS-CoV-2 structural proteins: a global analysis. Virol J 2022;19:220. [PMID: 36528612 DOI: 10.1186/s12985-022-01951-7] [Reference Citation Analysis]
2 Mteremko D, Chilongola J, Paluch AS, Chacha M. Targeting human thymidylate synthase: Ensemble-based virtual screening for drug repositioning and the role of water. Journal of Molecular Graphics and Modelling 2022. [DOI: 10.1016/j.jmgm.2022.108348] [Reference Citation Analysis]
3 Erol A. Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation. CMAR 2022;Volume 14:2339-56. [DOI: 10.2147/cmar.s373557] [Reference Citation Analysis]
4 Abavisani M, Rahimian K, Khayami R, Mollapour Sisakht M, Mahmanzar M, Meshkat Z. Mutational insights among the structural proteins of SARS-CoV-2: frequencies and evolutionary trends in American countries.. [DOI: 10.1101/2022.06.22.497134] [Reference Citation Analysis]